Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 16, 2009

Premium

Ludesi this week launched Redfin Solo, its new 2D gel image-analysis software with a payment model that allows users to pay only for analyses they believe is of value to them.

According to the company, after analysis of a project, the software asks a user to review the results and pay only for those they want. The cost is $30 per gel.

In a statement, Ludesi CEO Ola Forsstrom-Olsson said that budgets are tight and research grants are limited for many researchers. Meanwhile, the need for powerful analytical tools is increasing. "We have succeeded in creating a tool that completely sidesteps this potential conflict," he said.


Thermo Fisher Scientific this week launched the Subcellular Protein Fractionation Kit for the separation and preparation of cytoplasmic, membrane, nuclear soluble, chromatin-bound, and cytoskeletal protein extracts from mammalian cultured cells or tissue for protein localization studies or enrichment of specific cellular compartments.

The kit includes four extraction buffers, a stabilized nuclease, and the Thermo Scientific Halt Protease Inhibitor Cocktail. According to the firm, the simple protocol is completed in less than three hours and requires no ultracentrifugation over gradients during any of the steps. The subcellular extracts obtained are compatible with a variety of downstream applications, including protein assays, Western blotting, electrophoretic mobility assays, and enzyme activity assays, the company said.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.